Coronavirus: Commission approves contract with BioNTech-Pfizer alliance to ensure access to a potential vaccine

European Commission Press release Brussels, 11 Nov 2020 Today, the European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States.

Other news